Cavela lands $6.6M to help brands beat pre-tariff manufacturing costs; plus Function Health raises $298M Series B at $2.5B valuation by Unknown

Cavela lands $6.6M to help brands beat pre-tariff manufacturing costs; plus Function Health raises $298M Series B at $2.5B valuation

Written byUnknown
Narrated byUnknown
Length0h08m
Release dateNovember 20, 2025
★★★★☆ 4.5 (13 ratings)

Free with Audible trial. Cancel anytime.

Listen to a Sample

Hear Unknown's narration on Audible.

Play Sample on Audible

Quick Facts

AuthorUnknown
NarratorUnknown
Runtime0h08m
PublishedNovember 20, 2025
Rating★★★★☆ 4.5 / 5 (13 ratings)
CategoriesPolitics & Social Sciences, Politics & Government
FormatAudiobook (Digital)
PlatformAudible

About This Audiobook

When Anthony Sardain began developing Cavela in 2023, an AI startup that helps brands automate supplier sourcing, he did not foresee that new tariffs ...

Why Listen to Cavela lands $6.6M to help brands beat pre-tariff manufacturing costs; plus Function Health raises $298M Series B at $2.5B valuation?

  • Expert narration by Unknown brings every character and scene to life across 0h08m of immersive audio.
  • Bestseller-quality story from Unknown, rated 4.5 stars by 13 listeners.
  • Free with your Audible trial — keep the audiobook forever even if you cancel.
  • Perfect for commutes, workouts, and relaxation. Listen anywhere, anytime.
Start Listening Free

Download: Cavela lands $6.6M to help brands beat pre-tariff manufacturing costs; plus Function Health raises $298M Series B at $2.5B valuation

Some links on this page are affiliate links. If you make a purchase through one of them, we may earn a small commission at no extra cost to you.

Cavela lands $6.6M to help brands beat pre-tariff manufacturing costs; plus Function Health raises $298M Series B at $2.5B valuation by Unknown is an immersive listening experience. Performed by Unknown with a runtime of 0h08m, you can start with a free trial that you can cancel at any time. The audiobook remains yours forever, even if you end the trial.